Aviko Radiopharmaceuticals

The Head & Neck Cancer Alliance's 5th Annual Survivorship Symposium is being held tomorrow, October 5, in Philadelphia. Holly Schachner, MD, Chief Medical Officer, Aviko Radiopharmaceuticals and Chief Medical Officer, Deerfield Discovery and Development at Deerfield Management Company, will be in attendance to connect with and learn from #HeadandNeckCancer patients, survivors, caregivers and clinicians. If you will be at the symposium, reach out to Holly.   More about the event can be found here: https://lnkd.in/gEAfuFC4   To learn about how BNCT is being developed to treat head and neck cancers, read this blog post on our website: https://lnkd.in/ejQ9QW23   #CancerResearch #RadOnc #RadiationOncology #BNCT #BoronNeutronCaptureTherapy

Mark your calendars for this upcoming webinar from the #BoronNeutronCaptureTherapy subcommittee of Particle Therapy Cooperative Group (PTCOG). We’re looking forward to the discussion from fellow industry experts on the latest updates in #BNCT R&D. See more about the event below. #RadiationOncology #RadOnc #Radiotherapy #Radiopharmaceuticals

This past spring, Deerfield Management hosted a Summit on #BNCT that brought together academic and industry leaders from across the globe to discuss current technological advances, therapeutic developments, and operational requirements for the advancement of BNCT in the U.S. and global healthcare ecosystems. A summary of the Summit and recommendations for advancing BNCT are available in a recently published white paper, which can be found here: https://lnkd.in/giS5FeG9 We believe this white paper to be an expansive report on the current state of BNCT and it would be great to hear your thoughts about it. #BoronNeutronCaptureTherapy #ASTRO24 #RadiationOncology #RadOnc *Affiliates of Deerfield have a financial interest in Aviko.

We are looking forward to a presentation by Prof. Keiji Nihei (二瓶圭二), director of Kansai BNCT Medical Center and professor in the department of #RadiationOncology at Osaka Medical and Pharmaceutical University, on the “Clinical Experience with Accelerator-based BNCT systems in Japan,” at #ASTRO24 this upcoming Sunday, September 29 at 2:00 p.m. ET. This presentation is a great chance for attendees to learn more about how #BNCT is being used in Japan, where it was approved for recurrent head and neck cancer in 2020. #BoronNeutronCaptureTherapy #RadOnc

Will you be attending the American Society for Radiation Oncology (ASTRO)’s 66th Annual Meeting in Washington, D.C.? Stop by booth #1601 to connect with David Greenwald, Ph.D. and Holly Schachner, MD of Aviko Radiopharmaceuticals and Noah Smick of Neutron Therapeutics LLC, as well as the Leo Cancer Care team, to learn how we are working to advance #BoronNeutronCaptureTherapy (#BNCT). We’re looking forward to connecting with colleagues and learning more about your work! More info on the meeting here: https://lnkd.in/es7NzeV3 #ASTRO24 #RadOnc #Radiotherapy #Radiopharma #RadiationOncology #Radiopharmaceuticals

Be sure not to miss this incredible group of experts discussing #BNCT on a webinar organized by the International Atomic Energy Agency (IAEA). The webinar, “Advancements in Cancer Care through Boron Neutron Capture Therapy,” will be held Wednesday, September 25 at 3:00pm Central European Summer Time (9:00 a.m. EDT). Topics include the latest developments in BNCT, advantages compared to other treatments, and future directions for BNCT. Speakers include: Ian Swainson Igawa Kazuyo Yuan-Hao Liu WOLFGANG SAUERWEIN Rolf Barth Moderated by: Valentina Semkova Register here: https://lnkd.in/dzkvxZE7 #Radiopharmaceuticals #NuclearMedicine #RadiationOncology #RadOnc #BoronNeutronCaptureTherapy

Will you be attending the American Society for Radiation Oncology (ASTRO)’s 66th Annual Meeting in Washington, D.C.? Stop by booth #1601 to connect with David Greenwald, Ph.D. and Holly Schachner, MD of Aviko Radiopharmaceuticals and Noah Smick of Neutron Therapeutics LLC, as well as the Leo Cancer Care team, to learn how we are working to advance #BoronNeutronCaptureTherapy (#BNCT). We’re looking forward to connecting with colleagues and learning more about your work! More info on the meeting here: https://lnkd.in/es7NzeV3 #ASTRO24 #RadOnc #Radiotherapy #Radiopharma #RadiationOncology #Radiopharmaceuticals

#BoronNeutronCaptureTherapy is a precision approach to treating cancers that has experienced a resurgence in recent years, driven by scientific and technological innovations. Watch the video below to learn more about how our partner Neutron Therapeutics LLC's nuBeam® system will be used by researchers at Helsinki University Central Hospital (HUS), one of the leading centers for #BNCT research.   The video includes an overview of the science behind BNCT, describes advancements in this modality over the past few decades, and explains how Aviko, Neutron Therapeutics LLC, and Leo Cancer Care are advancing this approach for treating cancer at HUS. Learn more on our website: https://lnkd.in/gCgUrGbz #RadiationOncology #RadOnc #Radiotherapy #Radiopharmaceuticals (Disclaimer: The nuBeam® system is currently in development and has not received US marketing authorization from the FDA.)

Earlier this year we had the opportunity to speak with Jarmo, a patient treated with #BoronNeutronCaptureTherapy (#BNCT) over a decade ago by clinicians at Helsinki University Central Hospital (HUS).   Jarmo was not a typical candidate for BNCT, but his experience demonstrates the potential for BNCT to treat a variety of cancers.   Watch Jarmo share his story in the video below and on our website: https://lnkd.in/gMqQgEtv   #RadiationOncology #RadOnc #Radiotherapy #Radiopharmaceuticals   (Disclaimer: No Aviko Radiopharmaceuticals or Neutron Therapeutics products were used in Jarmo’s treatment. These companies’ products have not received marketing authorization from the FDA and they are not commercially available.)

Earlier this month at the Biotechnology Innovation Organization’s International Convention, David Greenwald, Ph.D., CEO of Aviko and vice president, business development at Deerfield Management, joined Seema Kumar, CEO of Cure., to discuss a recent report by Cure on the state of the #biotech industry.   Dave and Seema talked about the rise of #radiopharma over the last several years and the potential of #boronneutroncapturetherapy to treat cancer.    They also spoke about the growing optimism in the biotech sector, recent advances in #neuroscience, the future of AI in the life sciences and the importance of innovation in women’s health.   Check out the full interview here: https://lnkd.in/gsyfjhke   The report by Cure can be found here: https://lnkd.in/eN8atpQX   #BIO24 #BNCT #RadiationOncology #RadOnc #Radiotherapy #Radiopharmaceuticals